Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Detalles Bibliográficos
Autores principales: List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2015
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608406/
https://www.ncbi.nlm.nih.gov/pubmed/26648407
http://dx.doi.org/10.1038/leu.2015.312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608406/
https://www.ncbi.nlm.nih.gov/pubmed/26648407
http://dx.doi.org/10.1038/leu.2015.312

Ejemplares similares